Teva Pharma (TEVA) Tops Q1 EPS by 5c; updates guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 40.70 -1.39 (3.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.09 | 52 Week High | $66.55 | |||
| Open | $41.12 | 52 Week Low | $37.82 | |||
| Day High | $42.00 | P/E | N/A | |||
| Day Low | $40.63 | EPS | $0.00 | |||
| Volume | 10,586,814 | |||||
